34 Participants Needed

Financial Incentives + Communication Training for HPV Vaccine Uptake

KR
JG
Overseen ByJustin G Trogdon, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: UNC Lineberger Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores methods to help clinics enhance their communication about the HPV vaccine to boost vaccination rates. Some clinics will receive special communication training, known as Healthcare Provider Communication Training, while others will receive training plus financial incentives and feedback on their progress. The trial focuses on clinics in North Carolina with lower HPV vaccination rates among children aged 9-12 and no recent training or financial programs related to the vaccine. As an unphased trial, this study provides a unique opportunity to contribute to the improvement of public health communication strategies.

Will I have to stop taking my current medications?

The trial does not specify whether participants need to stop taking their current medications. However, since the trial involves clinics and their staff rather than individual patients, it is unlikely that personal medication changes are required.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that training healthcare providers to communicate better is safe. Many studies have examined how this training helps providers discuss the HPV vaccine and found no safety issues or negative effects from the training itself.

Regarding financial incentives, research indicates they can effectively increase vaccination rates, including for the HPV vaccine. These incentives are considered safe because they reward reaching certain goals, like higher vaccination rates, and there is no evidence that they harm participants.

Both communication training and financial incentives are well-received. They aim to improve vaccine uptake without directly affecting patients' health.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it combines communication training with financial incentives to boost HPV vaccine uptake. Unlike traditional methods that focus solely on educating patients or parents about the vaccine's benefits, this approach enhances the way clinic staff communicate about the HPV vaccine through the Announcement Approach Training. Additionally, the financial incentive program at the clinic level is a novel strategy aimed at encouraging higher vaccination rates by providing monthly feedback reports. This dual approach could lead to more effective vaccine advocacy and increased vaccination rates, addressing a key barrier in public health.

What evidence suggests that this trial's treatments could be effective for increasing HPV vaccine uptake?

This trial compares two approaches to increase HPV vaccine uptake. One arm involves communication training for healthcare providers, which studies have shown can increase HPV vaccine rates by about 5.2%. This training helps doctors and nurses explain the vaccine more clearly, encouraging parents to agree to it for their children. The other arm combines communication training with a financial incentive program. Research has shown that offering financial rewards can boost the number of people starting the HPV vaccine by around 10%. These rewards motivate clinics or providers to focus more on vaccination efforts. Both methods aim to simplify the decision for patients and their families to choose the HPV vaccine.24678

Who Is on the Research Team?

JG

Justin G Trogdon, PhD

Principal Investigator

University of North Carolina, Chapel Hill

Are You a Good Fit for This Trial?

This trial is for pediatric or family medicine clinics in North Carolina with less than a 72% HPV vaccine initiation rate and at least 50 patients aged 9-12. Clinics must have at least two providers offering the HPV vaccine and no recent financial incentives or communication training aimed at increasing vaccination rates.

Inclusion Criteria

Clinics eligible if they are a pediatric or family medicine clinic in North Carolina
My clinic has seen 50 or more patients aged 9-12 last year.
My clinic offers the HPV vaccine from 2 or more providers.
See 5 more

Exclusion Criteria

Clinics had an HPV initiation rate greater than 72%
Clinics had an HPV vaccine-specific financial incentive program in the past two years
Clinics with a specialty other than pediatrics or family medicine
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training and Intervention

Clinics receive communication training and some receive a financial incentive program with monthly data feedback

24 months

Follow-up

Participants are monitored for changes in HPV vaccination rates

24 months

What Are the Treatments Tested in This Trial?

Interventions

  • Communication training
  • Financial Incentive
Trial Overview The study is testing if giving clinics financial rewards, along with communication training, increases the number of kids getting the HPV vaccine. Some clinics will just get training, while others will also receive money based on their performance plus monthly progress reports.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: HPV vaccine communication training.Experimental Treatment1 Intervention
Group II: HPV vaccine communication training and clinic-level financial incentive programExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

Trials
377
Recruited
95,900+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A $1 increase in median provider payments for HPV vaccination is linked to a 0.48-percentage-point rise in the likelihood of adolescents starting the vaccine series, and a 0.25-percentage-point increase in those receiving two or more doses, indicating that financial incentives can significantly boost vaccination rates.
The impact of provider payments on HPV vaccine uptake is particularly pronounced in younger adolescents (ages 11-12) and those living in urban areas, suggesting targeted financial strategies could enhance vaccination efforts in these groups.
Provider Payments And The Receipt Of Human Papillomavirus Vaccine Among Privately Insured Adolescents.Tsai, Y., Lindley, MC., Zhou, F., et al.[2019]
This trial will evaluate two ECHO-delivered interventions aimed at increasing HPV vaccination rates among adolescents aged 11-14 in 36 primary care clinics, focusing on the effectiveness of provider training and parent recall notices.
The study aims to demonstrate that these interventions can improve HPV vaccination uptake, ultimately helping to prevent HPV-related cancers by addressing communication needs for both healthcare providers and parents.
Increasing the adoption of evidence-based communication practices for HPV vaccination in primary care clinics: The HPV ECHO study protocol for a cluster randomized controlled trial.Calo, WA., Shah, PD., Fogel, BN., et al.[2023]
An intervention combining behavioral nudges and provider communication training led to increased HPV vaccination rates in some pediatric practices, with 72% of parents reporting their child received the vaccine during the study visit.
Despite the overall increase in vaccination rates, concerns about vaccine safety and necessity persisted among some parents, highlighting the need for continued education and communication about HPV vaccinations.
A pilot intervention combining assessment and feedback with communication training and behavioral nudges to increase HPV vaccine uptake.Bradley-Ewing, A., Lee, BR., Doctor, JN., et al.[2022]

Citations

Clinician Communication Training to Increase Human ...Our findings indicated that clinician communication training could enhance vaccination uptake rates by an average of 5.2%. Specifically, presumptive ...
Interpersonal Communication Training and Vaccination ...Interpersonal communication training and vaccination workflow training alone or in combination may improve communication and recommendations for HPV vaccination ...
A scoping review of pediatric healthcare provider HPV ...The aim was to systematically analyze scientific literature assessing the use of implementation outcomes and behavior change theories to evaluate communication ...
Coaching and Communication Training for HPV VaccinationHPV vaccine initiation was 1.5% points higher in the QI coaching arm and 3.8% points higher in the combined intervention arm than in the control ...
Effect of Training Pediatric Clinicians in Human ...Online communication training reduced missed opportunities for HPV vaccination, particularly by improving receipt of the first HPV vaccine dose.
Coaching and Communication Training for HPV VaccinationWe sought to evaluate the effectiveness of combining QI coaching with remote provider communication training to improve impact.
Enhancing HPV Vaccine Uptake among Adolescents of ColorThis article focuses on provider communication strategies to promote HPV vaccine uptake effectively and equitably.
Clinician communication strategies associated with increased ...A growing body of literature examines specific communication strategies for promoting uptake of the HPV vaccine. A comprehensive review of the ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity